These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8393076)
1. Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunization with live virus. Irie H; Shimeld C; Williams N; Hill T J Gen Virol; 1993 Jul; 74 ( Pt 7)():1357-62. PubMed ID: 8393076 [TBL] [Abstract][Full Text] [Related]
2. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1. Morrison LA; Knipe DM Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723 [TBL] [Abstract][Full Text] [Related]
3. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. Morrison LA; Knipe DM J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine. Irie H; Harada Y; Kataoka M; Nagamuta M; Moriya Y; Handa M; Saito M; Matsubara S; Kojima K; Sugawara Y J Virol; 1992 Apr; 66(4):2428-34. PubMed ID: 1312638 [TBL] [Abstract][Full Text] [Related]
5. [T-cell-induced prevention of HSV-1 keratitis by immunization with the synthetic peptide of glycoprotein D]. Heiligenhaus A; Berra A; Dutt JE; Zhao TZ; Wells PA; Foster CS Ophthalmologe; 1994 Oct; 91(5):608-16. PubMed ID: 7812092 [TBL] [Abstract][Full Text] [Related]
6. Herpes. Vaccines for HSV. Stanberry LR Dermatol Clin; 1998 Oct; 16(4):811-6, xiv. PubMed ID: 9891686 [TBL] [Abstract][Full Text] [Related]
7. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Ritchie MH; Oakes JE; Lausch RN Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037 [TBL] [Abstract][Full Text] [Related]
8. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. Karem KL; Bowen J; Kuklin N; Rouse BT J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066 [TBL] [Abstract][Full Text] [Related]
9. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain. Klein RJ; Kaley LA; Friedman-Kien AE Vaccine; 1984 Sep; 2(3):219-23. PubMed ID: 6099650 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Morrison LA; Knipe DM Virology; 1996 Jun; 220(2):402-13. PubMed ID: 8661391 [TBL] [Abstract][Full Text] [Related]
11. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits. Nesburn AB; Slanina S; Burke RL; Ghiasi H; Bahri S; Wechsler SL J Virol; 1998 Oct; 72(10):7715-21. PubMed ID: 9733807 [TBL] [Abstract][Full Text] [Related]
12. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells. Ghasemi M; Erturk M; Buruk K; Sonmez M Cytotherapy; 2013 Mar; 15(3):352-61. PubMed ID: 23579060 [TBL] [Abstract][Full Text] [Related]
13. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice. Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849 [TBL] [Abstract][Full Text] [Related]
14. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Ghiasi H; Perng G; Nesburn AB; Wechsler SL Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911 [TBL] [Abstract][Full Text] [Related]
15. Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines. Kuklin NA; Daheshia M; Marconi PC; Krisky DM; Rouse RJ; Glorioso JC; Manican E; Rouse BT Virology; 1998 Jan; 240(2):245-53. PubMed ID: 9454698 [TBL] [Abstract][Full Text] [Related]